Royal Cornwall Hospitals NHS Trust

The trials here

What the 13 trials at this site are about, from their registry records.

Conditions

• Metastatic breast cancer3 trials
• Myelodysplastic syndromes2 trials
• Osteoarthritis2 trials
• Ovarian cancer2 trials
• Triple-negative breast cancer2 trials
• Acute myeloid leukaemia1 trial
• Chronic lymphocytic leukaemia1 trial
• Chronic myeloid leukaemia1 trial
• Coronary artery disease1 trial
• Diffuse large B-cell lymphoma1 trial
• Follicular lymphoma1 trial
• Hodgkin lymphoma1 trial
• and 2 more

Phase

• Phase 24 trials
• Phase 32 trials
• Phase 11 trial
• Phase 1/21 trial

Status

• Completed6 trials
• Active, not recruiting4 trials
• Recruiting2 trials
• Not yet recruiting1 trial

Lead sponsor

• Pfizer3 trials
• Faron Pharmaceuticals Ltd2 trials
• CENTOGENE GmbH Rostock1 trial
• Embody Orthopaedic Limited1 trial
• MedSIR1 trial
• and 5 more

Running trials

• Recruiting

  Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes

  NCT07672769· Phase 2· Faron Pharmaceuticals Ltd· Source

  Contact: Denise Storey

• Recruiting

  The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement

  NCT06162195· Embody Orthopaedic Limited· Source

  Contact: Camilla Halewood, PhD

• Recruiting

  This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

  NCT06758401· Phase 3· Pfizer· Source

• Active, not recruiting

  Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

  NCT05701358· Population Health Research Institute· Source

• Active, not recruiting

  A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies

  NCT05428969· Phase 1/2· Faron Pharmaceuticals Ltd· Source

• Active, not recruiting

  Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing

  NCT05059522· Phase 3· Pfizer· Source

• Active, not recruiting

  Total Ankle Replacement Versus Arthrodesis Trial

  NCT02128555· University College, London· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer1 recruiting
• Myelodysplastic syndromes1 recruiting
• Osteoarthritis1 recruiting

Closed trials

• Completed

  First Line Atezolizumab, Paclitaxel, and Bevacizumab (Avastin®) in mTNBC

  NCT04408118· Phase 2· MedSIR· Source

• Completed

  Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR

  NCT04295577· Royal Marsden NHS Foundation Trust· Source

• Completed

  Rostock International Parkinson's Disease Study (ROPAD)

  NCT03866603· CENTOGENE GmbH Rostock· Source

• Completed

  Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell Malignancies

  NCT02290951· Phase 1· Regeneron Pharmaceuticals· Source

• Completed

  PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer

  NCT02423603· Phase 2· Queen Mary University of London· Source

• Completed

  Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer

  NCT02007512· Phase 2· Pfizer· Source